Table 1.
Subject | Gender | Age (years) |
BMI | FEV1 (L) |
FEV1 (%) |
Tests sequence | PC20 MCh (mg/ml) | PC20 BK (mg/ml) |
1 | M | 23 | 23.8 | 3.24 | 76 | BK, EIB, MCh | 0.83 | 2.30 |
2 | M | 23 | 24.2 | 3.56 | 83 | EIB, BK, MCh | 0.21 | 0.15 |
3 | M | 21 | 24.0 | 2.98 | 69 | BK, EIB, MCh | 0.19 | 1.16 |
4 | F | 30 | 19.1 | 3.44 | 110 | MCh, EIB, BK | 1.13 | 3.87 |
5 | F | 43 | 24.8 | 2.55 | 83 | EIB, MCh, BK | 0.56 | 0.42 |
6 | F | 23 | 25.8 | 2.26 | 68 | MCh, BK, EIB | 0.13 | 0.58 |
7 | F | 45 | 25.7 | 2.13 | 80 | EIB, BK, MCh | 0.47 | 1.62 |
8 | F | 39 | 27.9 | 1.66 | 54 | MCh, BK, EIB | 0.14 | 0.12 |
9 | F | 24 | 33.6 | 2.81 | 87 | BK, MCh, EIB | 0.16 | 1.17 |
10 | F | 38 | 31.2 | 2.56 | 88 | BK, MCh, EIB | 1.00 | 0.22 |
11 | M | 39 | 22.1 | 2.90 | 74 | EIB, MCh, BK | 0.62 | 0.06 |
12 | F | 24 | 32.7 | 3.16 | 91 | MCh, EIB, BK | 0.17 | 1.16 |
13 | M | 24 | 19.2 | 3.73 | 90 | EIB, MCh, BK | 0.42 | 1.48 |
14 | M | 27 | 31.8 | 3.26 | 77 | MCh, BK, EIB | 0.28 | 2.37 |
15 | M | 46 | 26.8 | 3.29 | 83 | EIB, BK, MCh | 0.38 | 0.71 |
16 | M | 33 | 23.1 | 3.21 | 73 | BK, MCh, EIB | 2.35 | 2.32 |
17 | F | 24 | 19.6 | 2.57 | 80 | MCh, EIB, BK | 0.95 | 3.56 |
18 | F | 26 | 21.8 | 2.30 | 80 | MCh, EIB, BK | 0.15 | 0.20 |
19 | M | 38 | 24.6 | 2.25 | 64 | BK, MCh, EIB | 0.08 | 0.05 |
20 | M | 32 | 28.7 | 3.00 | 80 | MCh, BK, EIB | 0.58 | 1.73 |
Mean | 31 | 25.5 | 2.84 | 79.5 | 0.36a | 0.68a | ||
SD | 8 | 4.4 | 0.54 | 11.6 | 2.45b | 3.84b |
M: male; F: female; BMI: body mass index; FEV1: Forced expiratory volume in one second; MCh: methacoline; BK: bradykinin; EIB: exercise-induced bronchospasm; PC20: provocative concentration that results in a 20% fall in FEV1.
a geometric mean. b geometric standard deviation.